1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
(
- Contribution to journal › Article
- 2021
-
Mark
The power of genetic diversity in genome-wide association studies of lipids
(
- Contribution to journal › Article
- 2019
-
Mark
Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis
(
- Contribution to journal › Article
- 2018
-
Mark
Genome-wide analysis yields new loci associating with aortic valve stenosis
(
- Contribution to journal › Article
-
Mark
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
(
- Contribution to journal › Article
-
Mark
A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
(
- Contribution to journal › Article
-
Mark
New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals
(
- Contribution to journal › Article
-
Mark
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease
(
- Contribution to journal › Article